And this one tackles transplant policy with a global lens. Spread the word to trainees! .Policy Innovations to Advance Equity in Solid Organ Transplantation. July 25 – 10:00 AM (EDT) . Speakers: Elmi Muller, Peter Reese, Lisa McElroy, Jennifer Li (Chair).

And this one will be awesome too. Advancing Patient Monitoring, Diagnostics, and Treatment Strategies for Transplant Precision Medicine.📅 July 17, 2025 – 8:00 AM (EDT). 👥 Speakers: Alex Loupy, Marta Sablik, Peter Reese, Jennifer Li (Chair).@ParisTxGroup.

Fascinating webinar - open access!.Scientific Advances in the Assessment, Modification, and Generation of Transplantable Organs for Patients with End-Stage Organ Diseases. 📅 July 7 – 1:00 PM (EDT). 🔗 Matt Bacchetta, Ciara Shaver, Camille Kotton.

RT @TheLancet: Organ transplantation can save lives. 🫁 . However, challenges remain, including organ shortages and unequal access. A new….

RT @ParisTxGroup: 🔬 Just published in @TheLancet: a new Clinical Series on Solid Organ Transplantation, co-authored by experts around the g….

The field of transplant should commit to making this amazing therapy available to all who need it. Congratulations to Drs Jauré, Jha, McElroy, Muller, Oniscu, Serper, Purnell and Scholes-Robertson. @ESOTtransplant @AST_info .

Advances in precision immunosuppression will protect transplant recipients from immunosuppression’s toxicities. When the organ does suffer injury, new deep phenotyping tools will tell us why. Congratulations to Alex Loupy, Marta Sablik and Kiran Khush.

Incredible innovations will bring more organ transplants to more people and those organs will be able to travel further and function better. Congratulations to Drs Shaver, Bacchetta, Griesemer and Zuckermann. @ttsorg @VUMChealth .

Very exciting day - a group of exceptional scientists will publish a 3-part positive vision for the future of solid organ transplantation. These manuscripts will be open-access and accompanied by 3 webinars supported by @TheLancet @AST_info @ESOTtransplant @ttsorg @ParisTxGroup.

I can't wait to get to London for ESOT Congress 2025. The meeting will certainly feature new, important scientific developments. I am also fired up by fresh international collaborations designed to chart a bright future for patients with end-stage organ disease. @ESOTtransplant.

I see progress in figuring out how to guide immunosuppression toward individual patients' needs Amazing work here by Alex Loupy’s group illuminating how cell-free DNA reveals allograft inflammation, but a clinician needs to interpret in the clinical context. @AlexandreLoupy

Want to learn how the management of solid organ transplant recipients is being transformed by new technologies? Come to this free webinar! Led by the amazing Alex Loupy and rising star Marta Sablik. @ParisTxGroup @ESOTtransplant @thelancet

We need trials + AI based analysis to integrate biomarker data + learn how to customize the right immunosuppression meds + intensity for each patient. July 1 - we’ll offer an optimistic vision of that patient-centric future. @ast_info @ParisTxGroup @AlexandreLoupy @KiranKhush1.

Progress is here! Instead of one-size fits all dosing, we now have non-invasive measures of how immunosuppression affects each patient’s system: cell-free DNA, anti-HLA antibodies, gene expression, urine proteins e.g. CXCL10, anellovirus replication. @ESOTtransplant @TheLancet.

Transplant always faced a 2nd challenge: Toxicities of imprecise immunosuppression. Patients want a cure. Transplant provides more years + quality of life. Yet, the meds harm every organ system via infections, cancer, vascular dz, cognitive loss @ttsorg

We need trials. It may be a bumpy road, with medical complications. Treatment costs are unknown. Scale-up will be hard. But I believe we’ll solve these problems and make pig organ transplants part of usual care in ? 7 - 10 years. @thelancet @ttsorg @ESOTtransplant @VUMChealth.

Recently, several adults have received genetically modified pig kidney or heart transplants. Some transplants worked well, some failed early. Some early deaths, maybe due to selecting chronically ill patients. No one knows how to control chronic rejection.

In the 1960s! before modern immunosuppression, this surgeon did 6 chimpanzee kidney transplants into humans. A woman lived 9 months (then died suddenly). Today, modified pig organs are a better choice because we can 'make' pig organs faster. A good history

More evidence that scientific innovation will address the organ shortage: Xenotransplant. What many don’t realize is that Xeno’s a case of Back to the Future. Before I celebrate recent progress with CRISPR-modified pig organs, let me bring up Keith Reitsma @ast_info @ParisTxGroup.

RT @TheLancet: There is an urgent need to expand access to life-saving transplants. On July 7, join a webinar where experts will discuss n….